In the third phase, the Center aims to strengthen the Rare Disease Patient Engagement Guidance and Checklist‘s real-world utility, explore its applications to research in greater depth, and recognize excellence in patient-centered research. The goal of these efforts is to ensure that patients and caregivers are authentically involved in rare disease research so that CER and HTA include outcomes that are important to patients and coverage and payment decisions are not delayed.